✅ Product Introduction
Tglip M 20/1000 mg Tablet is a dual-acting oral antidiabetic medication combining Teneligliptin, a DPP-4 inhibitor, and Metformin, a first-line biguanide antidiabetic. This formulation is especially suitable for adults with type 2 diabetes mellitus who are unable to achieve adequate blood glucose control through lifestyle changes and Metformin alone. Teneligliptin enhances insulin release after meals, while Metformin works by decreasing hepatic glucose output and increasing insulin sensitivity.
💊 Uses of Tglip M Tablet
- Type 2 Diabetes Mellitus
- For patients with inadequate glycemic control on Metformin monotherapy
- As part of comprehensive diabetes management
🌟 Benefits of Tglip M Tablet
- Dual mechanism for better blood sugar control
- Controls both fasting and postprandial glucose levels
- May help in weight management
- Convenient once/twice-daily dosing improves patient compliance
- Reduces long-term risk of diabetic complications
🧪 Composition
Each tablet contains:
- Teneligliptin Hydrobromide Hydrate – 20 mg
- Metformin Hydrochloride (Sustained Release) – 1000 mg
⚠️ Side Effects
Common side effects:
- Stomach upset
- Diarrhea
- Loss of appetite
- Headache
- Hypoglycemia (especially if used with other anti-diabetics)
- Rare but serious:
- Lactic acidosis (linked to Metformin, especially in kidney dysfunction)
- Allergic skin reactions
🛡️ Safety Advice
- Dosage: Follow your doctor’s instructions strictly; take with food to reduce gastrointestinal discomfort.
- Kidney Monitoring: Important before and during treatment due to Metformin component.
- Alcohol: Avoid alcohol as it may increase the risk of lactic acidosis.
- Pregnancy & Breastfeeding: Use only if recommended by your doctor.
- Lifestyle: Combine with diet control, regular exercise, and routine glucose monitoring.
- Storage: Store in a cool, dry place away from direct heat or moisture.
